Abstract:Spherical nucleic acid (SNA) nanoparticle conjugates are a class of bionanomaterials that are extremely potent in many biomedical applications. Their unique ability to enter multiple mammalian cell types as single-entity agents arises from their novel three-dimensional architecture, which consists of a dense shell of highly oriented oligonucleotides chemically attached typically to a gold nanoparticle core. This architecture allows SNAs to engage certain cell surface receptors to facilitate entry. Here, we report studies aimed at determining the intracellular fate of SNAs and the trafficking events that occur inside C166 mouse endothelial cells after cellular entry. We show that SNAs traffic through the endocytic pathway into late endosomes and reside there for up to 24 h after incubation. Disassembly of oligonucleotides from the nanoparticle core is observed 16 h after cellular entry, most likely due to degradation by enzymes such as DNase II localized in late endosomes. Our observations point to these events being likely independent of core composition and treatment conditions, and they do not seem to be particularly dependent upon oligonucleotide sequence. Significantly and surprisingly, the SNAs do not enter the lysosomes under the conditions studied. To independently track the fate of the particle core and the fluorophore-labeled oligonucleotides that comprise its shell, we synthesized a novel class of quantum dot SNAs to determine that as the SNA structures are broken down over the 24 h time course of the experiment, the oligonucleotide fragments are recycled out of the cell while the nanoparticle core is not. This mechanistic insight points to the importance of designing and synthesizing next-generation SNAs that can bypass the degradation bottleneck imposed by their residency in late endosomes, and it also suggests that such structures might be extremely useful for endosomal signaling pathways by engaging receptors that are localized within the endosome.

PLGA Spherical Nucleic Acids.

Lipid Nanoparticle Spherical Nucleic Acids For Intracellular Dna And Rna Delivery

Cross-Linked Micellar Spherical Nucleic Acids From Thermoresponsive Templates

Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates

Spherical Nucleic Acids with Tailored and Active Protein Coronae

Structure-Dependent Biodistribution of Liposomal Spherical Nucleic Acids

Original Synthesis of a Nucleolipid for Preparation of Vesicular Spherical Nucleic Acids

A Spherical Nucleic Acid Platform Based on Self-Assembled DNA Biopolymer for High-Performance Cancer Therapy

A Facile Metal-Coordinated Spherical Nucleic Acid Nanoplatform for Enhanced Biological Applications by Avoiding Thiol Interference

The Sequence‐Specific Cellular Uptake of Spherical Nucleic Acid Nanoparticle Conjugates

DNA Polymer Nanoparticles Programmed Via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.

Long-lasting Cross-linked PLGA-Inspired Nanoparticles from One-pot Nanopolymerization of Precisely Sequenced Short Oligolactoglycolic Acid Dimethacrylates

Hollow Spherical Nucleic Acids for Intracellular Gene Regulation Based Upon Biocompatible Silica Shells

Antibody-linked spherical nucleic acids for cellular targeting.

Development of Multinuclear Polymeric Nanoparticles As Robust Protein Nanocarriers.

Therapeutic applications of spherical nucleic acids.

Tumor-Associated Enzyme-Activatable Spherical Nucleic Acids.

Protein-polymer nanoparticles for nonviral gene delivery.

Modified Nanoprecipitation Method to Fabricate Dna-Loaded Plga Nanoparticles

From Structure to Application: The Evolutionary Trajectory of Spherical Nucleic Acids

Defining the Design Parameters for in Vivo Enzyme Delivery Through Protein Spherical Nucleic Acids.